uu.seUppsala universitets publikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma
Visa övriga samt affilieringar
2014 (Engelska)Ingår i: Acta neuropathologica communications, ISSN 2051-5960, Vol. 2, artikel-id 174Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

TP53 mutations confer subgroup specific poor survival for children with medulloblastoma. We hypothesized that WNT activation which is associated with improved survival for such children abrogates TP53 related radioresistance and can be used to sensitize TP53 mutant tumors for radiation. We examined the subgroup-specific role of TP53 mutations in a cohort of 314 patients treated with radiation. TP53 wild-type or mutant human medulloblastoma cell-lines and normal neural stem cells were used to test radioresistance of TP53 mutations and the radiosensitizing effect of WNT activation on tumors and the developing brain. Children with WNT/TP53 mutant medulloblastoma had higher 5-year survival than those with SHH/TP53 mutant tumours (100% and 36.6%±8.7%, respectively (p<0.001)). Introduction of TP53 mutation into medulloblastoma cells induced radioresistance (survival fractions at 2Gy (SF2) of 89%±2% vs. 57.4%±1.8% (p<0.01)). In contrast, beta-catenin mutation sensitized TP53 mutant cells to radiation (p<0.05). Lithium, an activator of the WNT pathway, sensitized TP53 mutant medulloblastoma to radiation (SF2 of 43.5%±1.5% in lithium treated cells vs. 56.6±3% (p<0.01)) accompanied by increased number of gammaH2AX foci. Normal neural stem cells were protected from lithium induced radiation damage (SF2 of 33%±8% for lithium treated cells vs. 27%±3% for untreated controls (p=0.05). Poor survival of patients with TP53 mutant medulloblastoma may be related to radiation resistance. Since constitutive activation of the WNT pathway by lithium sensitizes TP53 mutant medulloblastoma cells and protect normal neural stem cells from radiation, this oral drug may represent an attractive novel therapy for high-risk medulloblastomas.

Ort, förlag, år, upplaga, sidor
2014. Vol. 2, artikel-id 174
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
URN: urn:nbn:se:uu:diva-262220DOI: 10.1186/s40478-014-0174-yPubMedID: 25539912OAI: oai:DiVA.org:uu-262220DiVA, id: diva2:852792
Tillgänglig från: 2015-09-10 Skapad: 2015-09-10 Senast uppdaterad: 2015-09-10Bibliografiskt granskad

Open Access i DiVA

fulltext(2438 kB)82 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 2438 kBChecksumma SHA-512
1a179c9fef8aab1c7345f93a1cf19eabd306ee4571551f2285e2125c2330a3a5e6576126704ecb5250178d9de4f3756641cd55f34e214a48942b42b8e9e3d20a
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Personposter BETA

Baskin, Berivan

Sök vidare i DiVA

Av författaren/redaktören
Baskin, Berivan
Av organisationen
Institutionen för immunologi, genetik och patologi
Cancer och onkologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 82 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 462 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf